Archived | Lexington’s SynapDx gets $2m as it looks to develop new autism test & Press Releases | Circa February 21, 2013 #NotAnAutisticAlly AGRE Collection

SynapDx logo Lexington’s SynapDx gets $2m as it looks to develop new autism test By Chris Reidy | Boston.com SynapDx Corp., a Lexington firm developing diagnostics for the earlier detection of autism, said Thursday that it has gotten $2 million in funding from Laboratory Corporation of America Holdings, or LabCorp, a North Carolina-based company that specializes …

Archived | Autism Speaks Portfolios: Autism Treatment | Circa 2007 #NotAnAutisticAlly

Portfolios: Autism Treatment The treatment of autism is the focus of one of four primary portfolios in the Autism Speaks Science Program. The Treatment Portfolio will focus on the areas of behavioral, biomedical and technological methods of treatment and intervention. Current and past initiatives in this area include the Innovative Technology for Autism Initiative, the Treatment Initiative and …

Archived | Autism Speaks: Autism Treatment Network | Circa 2007 #NotAnAutisticAlly

Image: Human head and shoulders silhouette with Not An Autistic Ally text and the logo for Autism Speaks Autism Treatment Network (ATN). Interactive autism network (ian) Autism Treatment Network (ATN) Autism INtervention Research Network on Physical Health Autism Treatment Network What is the ATN?  The Autism Treatment Network (ATN) is a network of treatment and …

Archived | Autism Speaks: Neural Retraining Initiative | Circa 2007 #NotAnAutisticAlly

Neural Retraining Initiative One of the most exciting stories in neuroscience in the last decade is the idea of neuroplasticity - the concept that the brain continues to grow, add new cells and change throughout life. There have been amazing breakthroughs in the treatment of stroke and dyslexia through neural retraining. Using specialized education techniques, …

Archived | Autism Speaks Portfolios: Autism Treatment Initiative & Grants | Circa 2007 #NotAnAutisticAlly

Treatment Initiative Currently there are no commonly accepted standards for autism treatment, and families are often left to navigate the course of their child's future on their own. Treatments vary regionally, and there is no system in place to coordinate the development of treatment protocols or novel therapeutics, nor their validation to qualify for insurance …

Archived | Autism Speaks: An Introduction to Clinical Trials | Circa 2007 #NotAnAutisticAlly

An Introduction to Clinical Trials Choosing to participate in a clinical trial is an important personal decision. The following frequently asked questions provide detailed information about clinical trials. In addition, it is often helpful to talk to a physician, family members, or friends about deciding to join a trial. After identifying some trial options, the …

Archived | Autism Speaks: Innovative Technology for Autism Initiative | Circa 2007 #NotAnAutisticAlly

Screenshot of Autism Speaks Innovative Technology for Autism Initiative web page circa 2007 Innovative Technology for Autism Initiative The Innovative Technology for Autism Initiative (ITA) was created to spur development of new technology to assist those living with autism. Its goal is to lead in the development of products that provide real world solutions to …